CYTC Insider Trading
CYTC | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CYTC provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2006-03-14 18:30 | 2006-03-13 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $29.83 | 2,500 | $74,579 | 23,538 | 0.0% |
| 2006-03-09 21:37 | 2006-03-08 | HATTOX BROCK A | Director, 10% owner | OPT+S | $29.37 | 1,000 | $29,367 | 2,417 | 0.0% |
| 2006-03-09 21:38 | 2006-03-08 | MESZNER ELTRICH A SUZANNE | Officer, 10% owner - Senior Vice President, General | OPT+S | $29.37 | 11,500 | $337,721 | 23,538 | 0.0% |
| 2006-02-21 18:26 | 2006-02-17 | PERSKY MARLA | Director | OPT+S | $29.45 | 13,500 | $397,564 | 2,084 | 0.0% |
| 2006-02-21 18:26 | 2006-02-17 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $29.74 | 3,000 | $89,225 | 23,538 | 0.0% |
| 2006-02-02 23:47 | 2006-02-01 | HATTOX BROCK A | Director | OPT+S | $30.58 | 1,000 | $30,584 | 2,417 | 0.0% |
| 2006-02-02 23:46 | 2006-02-01 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $30.58 | 4,500 | $137,629 | 23,538 | 0.0% |
| 2006-01-31 20:25 | 2006-01-30 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $30.18 | 7,000 | $211,272 | 23,538 | 0.0% |
| 2006-01-30 21:00 | 2006-01-27 | HATTOX BROCK A | Director | OPT+S | $30.01 | 500 | $15,007 | 2,417 | 0.0% |
| 2006-01-30 21:01 | 2006-01-27 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $30.01 | 3,000 | $90,044 | 23,538 | 0.0% |
| 2006-01-27 18:55 | 2006-01-26 | HATTOX BROCK A | Director | OPT+S | $29.15 | 1,000 | $29,150 | 2,417 | 0.0% |
| 2005-12-13 22:33 | 2005-12-09 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $29.44 | 11,000 | $323,840 | 2,663 | 0.0% |
| 2005-12-13 22:33 | 2005-12-09 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $29.44 | 9,000 | $264,960 | 23,538 | 0.0% |
| 2005-12-09 21:40 | 2005-12-08 | CRAWFORD SALLY | Director | OPT+S | $29.08 | 2,500 | $72,707 | 43,740 | 0.0% |
| 2005-12-09 21:41 | 2005-12-08 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $29.08 | 5,000 | $145,414 | 2,663 | 0.0% |
| 2005-12-09 21:41 | 2005-12-08 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $29.00 | 8,000 | $231,984 | 23,538 | 0.0% |
| 2005-12-08 21:55 | 2005-12-07 | CRAWFORD SALLY | Director | OPT+S | $29.04 | 2,000 | $58,075 | 43,740 | 0.0% |
| 2005-12-08 21:57 | 2005-12-07 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $29.01 | 5,000 | $145,042 | 2,663 | 0.0% |
| 2005-12-08 21:56 | 2005-12-07 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $28.94 | 9,769 | $282,686 | 23,538 | 0.0% |
| 2005-12-07 19:16 | 2005-12-06 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $28.89 | 8,231 | $237,788 | 23,538 | 0.0% |
| 2005-12-03 00:27 | 2005-12-01 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $28.32 | 10,000 | $283,198 | 2,663 | 0.0% |
| 2005-12-03 00:26 | 2005-12-01 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $28.32 | 6,500 | $184,079 | 23,538 | 0.0% |
| 2005-12-01 21:34 | 2005-11-30 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $27.29 | 18,667 | $509,422 | 2,663 | 0.0% |
| 2005-11-28 20:43 | 2005-11-23 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $26.89 | 5,000 | $134,450 | 2,663 | 0.0% |
| 2005-10-05 21:23 | 2005-10-05 | SULLIVAN PATRICK J | Director, Officer - Chief Executive Officer | OPT+S | $27.73 | 10,000 | $277,345 | 264,240 | 0.0% |
| 2005-10-04 17:37 | 2005-10-03 | MCDONOUGH JOHN P | Officer - Senior Vice President, | OPT+S | $27.59 | 6,000 | $165,536 | 917 | 0.0% |
| 2005-10-04 21:51 | 2005-10-03 | CRAWFORD SALLY | Director | OPT+S | $27.59 | 6,000 | $165,536 | 43,740 | 0.0% |
| 2005-10-04 21:52 | 2005-10-03 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $27.59 | 5,000 | $137,947 | 2,663 | 0.0% |
| 2005-09-30 00:08 | 2005-09-29 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $27.05 | 6,000 | $162,310 | 2,663 | 0.0% |
| 2005-09-28 17:08 | 2005-09-27 | MCDONOUGH JOHN P | Officer - Senior Vice President, | OPT+S | $27.00 | 4,000 | $108,000 | 917 | 0.0% |
| 2005-09-28 17:07 | 2005-09-27 | CRAWFORD SALLY | Director | OPT+S | $27.00 | 4,000 | $108,000 | 43,740 | 0.0% |
| 2005-09-28 17:08 | 2005-09-27 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $27.00 | 4,000 | $108,000 | 2,663 | 0.0% |
| 2005-09-12 18:40 | 2005-09-09 | MCDONOUGH JOHN P | Officer - Senior Vice President, | OPT+S | $25.75 | 5,000 | $128,763 | 917 | 0.0% |
| 2005-09-12 18:40 | 2005-09-09 | MCDANIEL C WILLIAM | Director | OPT+S | $25.75 | 33,330 | $858,331 | 20,000 | 0.0% |
| 2005-09-12 18:40 | 2005-09-09 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $25.75 | 5,000 | $128,763 | 2,663 | 0.0% |
| 2005-09-09 20:51 | 2005-09-08 | MCDONOUGH JOHN P | Officer - Senior Vice President, | OPT+S | $25.65 | 5,000 | $128,259 | 917 | 0.0% |
| 2005-09-09 20:51 | 2005-09-08 | MCDANIEL C WILLIAM | Director | OPT+S | $25.65 | 38,582 | $989,698 | 20,000 | 0.0% |
| 2005-09-09 20:50 | 2005-09-08 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $25.65 | 5,000 | $128,259 | 2,663 | 0.0% |
| 2005-09-08 21:40 | 2005-09-06 | MCDANIEL C WILLIAM | Director | OPT+S | $25.31 | 58,088 | $1,470,068 | 20,000 | 0.0% |
| 2005-08-15 19:48 | 2005-08-12 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $25.04 | 21,000 | $525,926 | 23,505 | 0.0% |
| 2005-08-04 20:41 | 2005-08-03 | MCDANIEL C WILLIAM | Director | OPT+S | $24.63 | 35,000 | $861,882 | 20,000 | 0.0% |
| 2005-07-29 21:35 | 2005-07-29 | MCDONOUGH JOHN P | Officer - Senior Vice President, | OPT+S | $25.98 | 5,000 | $129,880 | 917 | 0.0% |
| 2005-07-29 21:38 | 2005-07-29 | LEVANGIE DANIEL J | Director, Officer - Executive Vice President, | OPT+S | $25.21 | 762 | $19,210 | 69,076 | 0.0% |
| 2005-07-29 21:36 | 2005-07-28 | MESZNER ELTRICH A SUZANNE | Officer - Senior Vice President, General | OPT+S | $25.98 | 4,000 | $103,904 | 23,505 | 0.0% |
| 2005-07-29 21:35 | 2005-07-29 | BOOMER WALTER E | Director | OPT+S | $25.06 | 22,125 | $554,379 | 10,671 | 0.0% |
| 2005-07-29 18:50 | 2005-07-28 | SULLIVAN PATRICK J | Director, Officer - Chief Executive Officer | SELL | $25.44 | 48,000 | $1,221,341 | 264,240 | -15.4% |
| 2005-07-27 23:44 | 2005-07-27 | SULLIVAN PATRICK J | Director, Officer - Chief Executive Officer | SELL | $25.01 | 2,000 | $50,020 | 312,240 | -0.6% |
| 2005-07-11 18:00 | 2005-07-05 | SULLIVAN PATRICK J | Director, Officer - Chief Executive Officer | OPT+S | $22.21 | 30,000 | $666,321 | 314,240 | 0.0% |
| 2005-07-01 22:48 | 2005-07-01 | SULLIVAN PATRICK J | Director, Officer - Chief Executive Officer | OPT+S | $22.07 | 20,000 | $441,402 | 314,240 | 0.0% |
| 2005-06-15 19:02 | 2005-06-14 | LINDER JAMES | Officer - Sr. VP, Chief Medical Officer | OPT+S | $23.19 | 10,000 | $231,855 | 2,663 | 0.0% |
How to Interpret $CYTC Trades
Not every insider transaction in CYTC is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CYTC shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CYTC
Insider activity data for CYTC is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CYTC, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.